Daily Ards Research Analysis
Three ARDS-focused papers stand out today: a preclinical study shows pulsed focused ultrasound markedly enhances homing and retention of umbilical cord MSCs in the lung and improves injury in ARDS mice; a methodological comparison identifies a transtracheal catheter as the most robust, least variable LPS-induced ALI model; and a narrative review maps CT, PET, and EIT imaging readouts in animal models to human pathophysiology, strengthening translational alignment.
Summary
Three ARDS-focused papers stand out today: a preclinical study shows pulsed focused ultrasound markedly enhances homing and retention of umbilical cord MSCs in the lung and improves injury in ARDS mice; a methodological comparison identifies a transtracheal catheter as the most robust, least variable LPS-induced ALI model; and a narrative review maps CT, PET, and EIT imaging readouts in animal models to human pathophysiology, strengthening translational alignment.
Research Themes
- Enhancing cell therapy efficacy in ARDS via focused ultrasound
- Standardizing and optimizing preclinical ALI/ARDS models
- Translational imaging bridging animal models and human pathophysiology
Selected Articles
1. Ultrasound assisted homing of human umbilical cord mesenchymal stem cells promotes recovery from acute respiratory distress syndrome.
In an LPS-induced ARDS mouse model, pulsed focused ultrasound significantly enhanced lung homing and retention of hUC-MSCs up to day 6, reduced BALF inflammatory cells and lung Tnf/Il1b/Il6 expression, and improved histologic injury. Mechanistically, pFUS increased SDF-1, ICAM-1, CXCL5, and IGF-1 in lung tissue, supporting a homing-favorable microenvironment.
Impact: This study addresses a key translational bottleneck—insufficient MSC homing—by introducing a noninvasive adjunct (pFUS) that enhances therapeutic cell delivery and efficacy in ARDS.
Clinical Implications: While preclinical, the findings support evaluating ultrasound preconditioning to augment MSC therapies for ARDS, informing dose/parameter selection and biomarker endpoints (e.g., SDF-1, ICAM-1).
Key Findings
- pFUS increased hUC-MSC lung homing and retention, detectable up to day 6 by bioluminescence imaging.
- Inflammation and injury decreased with pFUS+MSCs: fewer BALF inflammatory cells, lower Tnf/Il1b/Il6 expression, fewer TUNEL+ cells, and higher PCNA+ cells.
- pFUS upregulated homing-associated factors SDF-1, ICAM-1, CXCL5, and IGF-1 in lung tissue.
- Therapeutic effects were greater with pFUS+MSCs than MSCs alone (P<0.05).
Methodological Strengths
- In vivo longitudinal tracking of MSC homing/retention by bioluminescence imaging (1–7 days).
- Multimodal endpoints: histology, BALF cell counts, cytokine expression, TUNEL/PCNA, and transcriptomic validation.
Limitations
- Murine LPS-induced ARDS model may not capture full clinical heterogeneity.
- Sample size and power are not explicitly reported.
- Safety, dosing, and parameter optimization of pFUS were not systematically evaluated; no large-animal validation.
Future Directions: Define pFUS parameters and timing, test across ARDS etiologies and in large-animal models, and evaluate safety/feasibility in early-phase clinical trials with imaging and biomarker endpoints.
BACKGROUND: Human umbilical cord mesenchymal stem cells (hUC-MSCs) show potential for treating acute respiratory distress syndrome (ARDS), however, their homing to the lungs and survival time are insufficient. In this study, we evaluated whether pulsed focus ultrasound (pFUS) could promote the homing and prolonged retention of hUC-MSCs in the lungs of ARDS mice and explored the mechanisms involved. METHODS: Mice were divided into four groups: the NC group, the LPS group, the MSCs group, and the pFUS + MSCs group. Except for the NC group, the other three groups were constructed as ARDS models and given PBS, MSCs and pFUS + MSCs interventions. hUC-MSCs were used to assess lung tissue injury by HE staining, inflammatory cell count in alveolar lavage fluid (BALF), and expression of Tnf, Il1b and Il6 in the lung tissues; and apoptosis and proliferation in the lung tissues were assessed by TUNEL and immunofluorescence. Bioluminescence imaging was used to detect the homing rate and survival of hUC-MSCs in mouse lungs from 1 to 7 days. Cxcl5 and Igf1 was found to be differentially expressed and highly enriched by mRNA sequencing in MSC and sonicated groups and verified by PCR combined with ELISA. RESULTS: Compared with the LPS group, the lung inflammatory infiltrate and lung tissue damage in the MSCs group and pFUS + MSC group were alleviated, the number of inflammatory cells in the BALF and the expression of Tnf, Il1b and Il6 in the lung tissues were reduced, the expression of TUNEL-positive cells was reduced, and the expression of PCNA-positive cells was increased, and the decrease or increase was more significant in the pFUS + MSC group (P < 0.05). pFUS increased the number of hUC-MSCs homing in the lungs and prolonged lung survival to day 6 and significantly up-regulated lung tissue levels of SDF-1, ICAM-1, CXCL5 and IGF-1 compared to the MSCs group (P < 0.05). CONCLUSIONS: pFUS preconditioning may improve lung homing and prolong survival of hUC-MSCs by upregulating the levels of homing-associated factors SDF-1, ICAM-1, CXCL5 and IGF-1, which in turn improves ARDS.
2. Comparative Evaluation of Lipopolysaccharide Administration Methods to Induce Acute Lung Injury in Murine Models: Efficacy, Consistency, and Technical Considerations.
Across four LPS delivery techniques, surgical transtracheal catheterization yielded the highest lung injury scores, greater BALF cellularity and IL-6, and the least variability, with more lung-localized dye distribution. Sex differences were evident, with males showing more severe injury.
Impact: Standardizing LPS administration provides a more robust and reproducible ALI phenotype, directly improving preclinical study design and interpretability in ARDS research.
Clinical Implications: While preclinical, choosing lower-variability models may accelerate translational pipelines by yielding clearer efficacy signals and informing sex-inclusive designs.
Key Findings
- Transtracheal catheter delivery produced the highest lung injury scores and least variability versus intratracheal intubation and intranasal routes.
- Surgical transtracheal methods led to higher alveolar neutrophils, more proteinaceous debris, fewer hyaline membranes, and higher BALF total cells and IL-6.
- Evans Blue dye distribution was more localized to lungs with transtracheal methods.
- Male mice had more severe injury and higher BALF protein than females.
Methodological Strengths
- Head-to-head comparison of four commonly used LPS delivery techniques with multimodal endpoints.
- Inclusion of both sexes and objective localization assessment using Evans Blue dye.
Limitations
- Single strain, dose (2.25 mg/kg), and 72-hour timepoint may limit generalizability.
- Increased procedural complexity for surgical methods may affect feasibility and external reproducibility.
Future Directions: Benchmark physiologic and survival endpoints across methods, evaluate different LPS doses/strains/ages, and develop training standards to disseminate the optimal technique.
CONTEXT: Direct preclinical lipopolysaccharide acute lung injury (ALI) models are commonly used to study acute respiratory distress syndrome. Differences in lipopolysaccharide delivery methods may impact lung injury severity and reproducibility. HYPOTHESIS: We hypothesized that the severity and variability of ALI outcomes in mice would differ depending on the technique of lipopolysaccharide administration. METHODS AND MODELS: Male and female C57BL/6 mice were administered lipopolysaccharide (2.25 mg/kg) via four methods: 1) intratracheal intubation; 2) intranasal; 3) surgical transtracheal by either needle puncture; or 4) by catheter. ALI severity and variability were assessed at 72 hours post-lipopolysaccharide via histological scoring and bronchoalveolar lavage fluid (BALF) analysis (total protein, cell counts, interleukin-6 [IL-6]). The relative distribution of Evans Blue dye was also assessed for each model (lungs vs. stomach). RESULTS: Distinct lung injury patterns were observed between the four methods. The transtracheal with catheter method demonstrated significantly greater lung injury scores than the intratracheal intubation and intranasal techniques. Both transtracheal methods produced greater alveolar neutrophil counts, increased proteinaceous debris, fewer hyaline membranes, and lower variability than non-surgical techniques. The transtracheal with catheter method produced higher BALF total cell counts and IL-6 levels than intratracheal intubation. Transtracheal methods also resulted in more localized Evans Blue dye distribution in the lungs. Male mice exhibited more severe lung injury scores and higher BALF protein concentrations than females. INTERPRETATION AND CONCLUSIONS: This study demonstrates that the choice of technique to administer lipopolysaccharide impacts injury severity, phenotype, and variability. The surgical transtracheal with catheter technique produced the most robust and least variable ALI phenotype; however, this technique is associated with increased procedural complexity. Our results will allow researchers to tailor their model choice to align with their specific study objectives.
3. Imaging in animal models: bridging experimental findings and human pathophysiology.
This narrative review synthesizes how CT, PET, and EIT in animal models capture structural and functional lung changes paralleling human ARDS, COPD, and fibrosis. It highlights EIT as a radiation-free modality and underscores the translational alignment of imaging biomarkers and physiology.
Impact: By mapping preclinical imaging endpoints to human pathophysiology, the review guides design of translational studies and selection of clinically relevant imaging biomarkers.
Clinical Implications: Encourages incorporating EIT and standardized CT/PET protocols in preclinical ARDS studies to better predict ventilatory management strategies and therapeutic responses in ICU patients.
Key Findings
- CT, PET, and EIT enable in vivo assessment of lung structure and function in animal models relevant to human critical illness.
- EIT offers radiation-free monitoring, supporting longitudinal assessments and ventilatory strategy evaluation.
- Many imaging and physiological signatures in animal models mirror those in critically ill patients, enhancing translational relevance.
Methodological Strengths
- Comprehensive synthesis across multiple imaging modalities with explicit translational focus.
- Clear discussion of modality-specific advantages/limitations (e.g., radiation vs. radiation-free).
Limitations
- Narrative review without systematic search or quantitative synthesis may introduce selection bias.
- Heterogeneity across animal models and protocols limits direct comparability.
Future Directions: Develop standardized, shareable imaging protocols and multicenter preclinical imaging consortia; integrate multimodal imaging with functional and clinical endpoints for stronger translational bridges.
Acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis are major respiratory conditions associated with significant morbidity and, in some cases, high mortality. A variety of animals models have been established to study these disorders, primarily focusing on histologic alterations, cellular signalling pathways, inflammatory responses, lung perfusion, gas-exchange abnormalities, and response to emerging therapies. Imaging techniques play a crucial role in these investigations, enabling in vivo assessment of lung structure and function. The most widely used imaging modalities include computed tomography (CT), positron emission tomography (PET), and electrical impedance tomography (EIT). While CT and, to a variable extent, PET involve ionizing radiation, EIT is a radiation-free technique. Despite anatomical differences between species, many imaging and physiological findings observed in animal models are consistent with those seen in critically ill patients, enhancing their translational relevance. This narrative review provides a comprehensive overview of the applicability of these imaging techniques in animal models and explores their relevance to human pathophysiology and clinical management.